Variations in plasma concentrations of atrial natriuretic peptide (ANP), endothelin-1 (ET-1) and von Willebrand factor (vWF) could indicate pulmonary artery systolic pressure (PASP) in newborns suffering from PPHN throughout their treatment. The gene discussed is VWF; the disease is persistent fetal circulation syndrome.